Kaisa Tarkkanen
Chief Executive Officer at Med Group Oy
Profile
Kaisa Tarkkanen currently works as a Managing Director at Med Group Oy.
He is currently working as a Director at Solubility co.
ltd.
Kaisa Tarkkanen active positions
| Companies | Position | Start |
|---|---|---|
Med Group Oy
 Med Group Oy Medical/Nursing ServicesHealth Services Med Group Oy provides healthcare services. It offers ambulance, home, dental, and eye care as well as medical personnel staffing services. The company was founded by Atte Kustaa Piha and Ali Omar in 2007 and is headquartered in Vantaa, Finland. | Chief Executive Officer | - |
Solubility co. ltd
 Solubility co. ltd Miscellaneous Commercial ServicesCommercial Services Solubility Co. Ltd is a preclinical contract research organization that provides physicochemical measurement services using the proprietary SPA method. The company is based in an undisclosed location and their team is driven to success. The Finnish company's focus is on assisting early-stage decision-making by providing crucial information about substances in development. The company was founded in 2013 and is led by CEO Sami Svanbäck. | Director/Board Member | 01/06/2020 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Med Group Oy
Med Group Oy Medical/Nursing ServicesHealth Services Med Group Oy provides healthcare services. It offers ambulance, home, dental, and eye care as well as medical personnel staffing services. The company was founded by Atte Kustaa Piha and Ali Omar in 2007 and is headquartered in Vantaa, Finland. | Health Services |
Solubility co. ltd
Solubility co. ltd Miscellaneous Commercial ServicesCommercial Services Solubility Co. Ltd is a preclinical contract research organization that provides physicochemical measurement services using the proprietary SPA method. The company is based in an undisclosed location and their team is driven to success. The Finnish company's focus is on assisting early-stage decision-making by providing crucial information about substances in development. The company was founded in 2013 and is led by CEO Sami Svanbäck. | Commercial Services |
- Stock Market
- Insiders
- Kaisa Tarkkanen
